ZA901945B - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
ZA901945B
ZA901945B ZA901945A ZA901945A ZA901945B ZA 901945 B ZA901945 B ZA 901945B ZA 901945 A ZA901945 A ZA 901945A ZA 901945 A ZA901945 A ZA 901945A ZA 901945 B ZA901945 B ZA 901945B
Authority
ZA
South Africa
Prior art keywords
formula
compound
ace
inhibitor
methyl
Prior art date
Application number
ZA901945A
Other languages
English (en)
Inventor
Patrick Coleman O'connor
Coleman O'connor Patrick
Charles Leon-Marie Defesche
Leon-Marie Defesche Charles
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of ZA901945B publication Critical patent/ZA901945B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA901945A 1989-03-15 1990-03-14 Therapeutic agents ZA901945B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32421389A 1989-03-15 1989-03-15

Publications (1)

Publication Number Publication Date
ZA901945B true ZA901945B (en) 1991-01-30

Family

ID=23262607

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA901945A ZA901945B (en) 1989-03-15 1990-03-14 Therapeutic agents

Country Status (13)

Country Link
EP (1) EP0527720B1 (da)
JP (1) JPH04503806A (da)
KR (1) KR920700642A (da)
AT (1) ATE109981T1 (da)
AU (1) AU640128B2 (da)
CA (1) CA2049980A1 (da)
DE (1) DE69011692T2 (da)
DK (1) DK0527720T3 (da)
ES (1) ES2057542T3 (da)
IE (1) IE65902B1 (da)
IL (1) IL93744A (da)
WO (1) WO1990010445A1 (da)
ZA (1) ZA901945B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0651640A1 (en) * 1992-07-21 1995-05-10 Knoll AG Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat

Also Published As

Publication number Publication date
IE65902B1 (en) 1995-11-29
CA2049980A1 (en) 1990-09-16
JPH04503806A (ja) 1992-07-09
DE69011692D1 (de) 1994-09-22
IL93744A (en) 1995-06-29
IE900818L (en) 1990-09-15
KR920700642A (ko) 1992-08-10
DE69011692T2 (de) 1994-12-01
IL93744A0 (en) 1990-12-23
AU640128B2 (en) 1993-08-19
WO1990010445A1 (en) 1990-09-20
AU5261690A (en) 1990-10-09
EP0527720B1 (en) 1994-08-17
DK0527720T3 (da) 1994-12-05
EP0527720A1 (en) 1993-02-24
ATE109981T1 (de) 1994-09-15
ES2057542T3 (es) 1994-10-16

Similar Documents

Publication Publication Date Title
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
HK1003978A1 (en) Composition for the treatment of schizophrenia
IE894048L (en) New therapeutically active compound and a process for its¹preparation
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
DE69420872D1 (de) Hgh enthaltende pharmazeutische zubereitungen
IL112098A0 (en) Sulfamate derivatives and pharmaceutical compositions containing them
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
IL93744A0 (en) Therapeutic agents
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
GB1375806A (da)
IL89126A0 (en) Beta-lactam antibiotics,their preparation and pharmaceutical compositions containing them
PT85815A (en) Process for the preparation of a pharmaceutical compound for the treatment of high blood pressure containig as active ingredient a mixture of proline with a conversion inhibitor of the angiotensine enzyme and thiazide
CA2154485A1 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
MY110416A (en) Composition for the treatment of schizophrenia.
EP0980366A4 (en) ANTITHROMOSIS
PT94787A (pt) Processo de preparacao de composicoes farmaceuticas para administracao transdermica de corticosteroides e de compostos com actividade fisiologica semelhante
IT1254191B (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
IT1255380B (it) Nitrobenzoilalanine,procedimento per la loro preparazione,loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono
JO1531B1 (en) New near-compounds